Cme (CME) Receivables (2009 - 2026)

Cme (CME) has 18 years of Receivables data on file, last reported at $935.5 million in Q1 2026.

• Quarterly Receivables rose 21.46% year-over-year to $935.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $935.5 million (up 21.46% YoY) and the FY2025 annual result came in at $639.2 million, up 11.53% from the prior year.
• Receivables improved to $935.5 million in Q1 2026 per CME's latest filing, from $639.2 million in the prior quarter.
• Across five years, Receivables topped out at $935.5 million in Q1 2026 and bottomed at $483.2 million in Q4 2022.
• The 5-year median for Receivables is $608.9 million (2022), against an average of $632.8 million.
• The widest annual swing landed in 2022, when Receivables rose 23.34%; it then declined 13.18% in 2024.
• Tracing CME's Receivables over 5 years: stood at $483.2 million in 2022, then increased by 10.84% to $535.6 million in 2023, then grew by 7.0% to $573.1 million in 2024, then increased by 11.53% to $639.2 million in 2025, then surged by 46.35% to $935.5 million in 2026.
• Per Business Quant, the three latest CME Receivables figures stand at $935.5 million (Q1 2026), $639.2 million (Q4 2025), and $642.9 million (Q3 2025).

Peer Comparison